Sanofi SNY
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$40.17$40.87
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
--
EPS (TTM)
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | 13.49B | 13.16B | 11.34B | 10.41B | |
| Total Other Revenue | 817.64M | 1.05B | 840.98M | 748.22M | |
| Total Revenue | 14.31B | 14.21B | 12.18B | 11.16B | |
| Cost of Revenue | 3.36B | 4.23B | 3.40B | 3.04B | |
| Gross Profit | 10.95B | 9.98B | 8.79B | 8.12B | |
| SG&A Expenses | 2.90B | 3.28B | 2.63B | 2.34B | |
| Depreciation & Amortization | 642.02M | 626.28M | 429.00M | 419.89M | |
| Other Operating Expenses | 1.80B | 1.38B | 1.62B | 1.15B | |
| Total Operating Expenses | 11.30B | 12.18B | 10.24B | 8.85B | |
| Operating Income | 3.01B | 2.03B | 1.94B | 2.31B | |
| Income Before Tax | 963.03M | -1.34B | 1.66B | 2.32B | |
| Income Tax Expenses | 524.55M | -405.11M | 261.03M | 506.18M | |
| Earnings from Continuing Operations | 438.48M | -939.43M | 1.40B | 1.81B | |
| Earnings from Discontinued Operations | 0.00 | 15.13M | 3.07B | 183.11M | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -39.54M | -8.15M | -4.54M | -22.10M | |
| Net Income | 398.94M | -932.44M | 4.47B | 1.97B | |
| EBIT | 3.01B | 2.03B | 1.94B | 2.31B | |
| EBITDA | 4.45B | 4.06B | 2.87B | 2.73B | |
| EPS Basic | 0.33 | -0.77 | 3.67 | 1.60 | |
| Normalized Basic EPS | 1.42 | 1.02 | 1.01 | -- | |
| EPS Diluted | 0.33 | -0.77 | 3.67 | 1.60 | |
| Normalized Diluted EPS | 1.42 | 1.02 | 1.01 | -- | |
| Average Basic Shares Outstanding | 1.20B | 1.21B | 1.22B | 1.23B | |
| Average Diluted Shares Outstanding | 1.20B | 1.21B | 1.22B | 1.23B | |
| Dividend Per Share | -- | 4.80 | -- | -- | |
| Payout Ratio | 1,435.28% | -595.76% | 121.12% | -- | |